Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Tilidine is a synthetic opioid analgesic developed in Germany in the late 1960s and introduced to the market in 1970. It is primarily used for the treatment of moderate to severe acute and chronic pain, including postoperative and cancer-related pain. As a prodrug, Tilidine is rapidly metabolized in the liver and gut to its active metabolite, nortilidine, which exerts its analgesic effects. To mitigate abuse potential, Tilidine is frequently co-formulated with naloxone, an opioid antagonist.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Tilidine.